Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
If your budget isn’t sticking, you’re not alone. Here are common reasons budgets fail and simple adjustments you can make right away.
20,953 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
Traders are flocking to ultra-short bets on Bitcoin’s price moves. In rapid-fire windows, platforms report record vol...
As China deepens ties with Iran, oil routes and market expectations shift. A veteran strategist highlights China’s gr...
Oklo rose 5% and NuScale Power gained 3% in early trading as investors renewed interest in nuclear energy stocks amid...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
Binance announced a sweeping delisting of eight altcoins, sending prices lower and forcing traders to reassess holdin...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
Major League Baseball announces a formal partnership with Polymarket and an integrity pact with the CFTC to guide pre...